Experience in using specific recombinant monoclonal antibodies in comorbid patients with coronavirus infection
Introduction: against the background of the ongoing incidence of coronavirus infection, the selection of therapy often requires individual approaches, especially in comorbid patients. Despite the emergence of specific prevention methods and new antiviral drugs, there are risk groups for severe disea...
Saved in:
Main Authors: | S. A. Sokotun, A. I. Simakova, A. O. Mikhailov, N. G. Plekhova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Journal Infectology
2024-12-01
|
Series: | Журнал инфектологии |
Subjects: | |
Online Access: | https://journal.niidi.ru/jofin/article/view/1710 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Direct antiviral drugs and blocking monoclonal antibodies as the basis of etiotropic therapy of a novel coronavirus infection
by: V. B. Musatov
Published: (2022-10-01) -
In vitro expression of SARS coronavirus (SARS-CoV) nucleocapsid protein and examination of the function of monoclonal antibody induced by the expressed protein
by: CHEN Hong-xun, et al.
Published: (2005-03-01) -
Production and characterization of monoclonal antibody to recombinant chicken IL-2
by: LI Zeng-kui, et al.
Published: (2004-09-01) -
Study on the monoclonal antibody to chlorpyrifos
by: JIN Ren-yao, et al.
Published: (2006-11-01) -
Obtaining and Characterization of Hybridomas Producing Monoclonal Antibodies against Coronavirus SARS-CоV-2
by: G. V. Kuklina, et al.
Published: (2023-05-01)